| ¿µ¹® | histamine | ÇÑ±Û | È÷½ºÅ¸¹Î |
|---|---|---|---|
| ¼³¸í | È÷½ºÅ¸¹ÎÀ̶õ ºñ¸¸¼¼Æ÷°ú È£¿°±â±¸¶ó´Â ¼¼Æ÷¿¡ ¸¹ÀÌ ÀÖ´Â ¹°Áú·Î½á ±â´ÉÀº ´ÙÀ½°ú °°´Ù. 1. ¸ð¼¼Ç÷°üÀÇ À̿ϰú Åõ°ú¼ºÀÇ Áõ°¡ 2. ³»Àå¿¡ ºÐÆ÷ÇÏ´Â ±ÙÀ°ÀÇ ¼öÃà 3. À§»êÀÇ ºÐºñÃËÁø 4. ½ÉÀå¹Úµ¿¼öÀÇ Áõ°¡ È÷½ºÅ¸¹ÎÀÌ ºÐºñµÇ¾î ´Ù¸¥ ¼¼Æ÷¿¡ ¿µÇâÀ» ÁÖ¾î À§¿Í °°Àº ¿ªÇÒÀ» ÇÏ·Á¸é ¹Ýµå½Ã ¼¼Æ÷Ç¥¸é¿¡ ÀÖ´Â È÷½ºÅ¸¹Î ¼ö¿ëü¿Í °áÇÕÀ» ÇÏ¿©¾ßÇÑ´Ù. ÀÌ È÷½ºÅ¸¹Î ¼ö¿ëü¿¡´Â µÎ °¡Áö°¡ ÀÖ´Ù. Çϳª´Â H1-¼ö¿ëü¶ó°í ÇÏ´Â °ÍÀε¥ ÀÌ ¼ö¿ëü´Â À§ÀÇ ÀÛ¿ëÁß¿¡¼ 1, 2¹øÀÇ ÀÛ¿ëÀ» ¸Å°³ÇÑ´Ù. Áï H1-¼ö¿ëü¿¡ È÷½ºÅ¸¹ÎÀÌ ºÎÂøÇÒ ¶§¿¡ À§ÀÇ 1, 2¹ø°ú °°Àº ÀÛ¿ëÀÌ ÀϾÙ. ´Ù¸¥ Çϳª´Â H2-¼ö¿ëü¶ó°í ÇÏ´Â °ÍÀε¥ 3, 4¹øÀÇ ÀÛ¿ëÀ» ¸Å°³ÇÑ´Ù. ±×¸®°í ¾ÈƼÈ÷½ºÅ¸¹Îµµ °¢°¢ H1-¼ö¿ëü¿¡ ÀÛ¿ëÇÏ´Â °ÍÀÌ ÀÖ°í, H2-¼ö¿ëü¿¡ ÀÛ¿ëÇÏ´Â °ÍÀÌ ÀÖ´Ù. |
||
| AHT | aggregation half time; antihyaluronidase titer; augmented histamine test; autogenous hamster tumor |
|---|---|
| H2 | blockers histamine blockers |
| HA | H antigen; Hakim-Adams [syndrome]; halothane anesthesia; Hartley [guinea pig]; headache; health alli... |
| HAP | Handicapped Aid Program; Hazardous Air Pollutants [List]; hazardous air pollution; health alliance p... |
| HC | hair cell; hairy cell; handicapped; head circumference; head compression; health care; healthy contr... |
| CPAF | Chlorpropamide-alcohol flush |
|---|---|
| 4-MH | 4-methyl histamine |
| H | Histamine |
| H2 | Histamine |
| HA | Histamine |
| histamine flush | Vasodilatation and erythema occurring as a result of release of histamine; thought to be a factor in genesis of flush of carcinoid syndrome. (05 Mar 2000) |
|---|
| carcinoid flush | Periodic hyperaemia (flushing) of the skin of the face and other parts of the body seen in patients with a carcinoid tumour; the mediator has not been identified but it is not serotonin; flush can be precipitated by alcohol, food, stress, or palpation of the liver. (05 Mar 2000) |
|---|---|
| malar flush | Localised hectic flush and warmth of the malar eminences, often occurring in tuberculosis and sometimes seen in rheumatic fever. (05 Mar 2000) |
| hectic flush | Redness of the face associated with a rise of temperature in various fevers. (05 Mar 2000) |
| hot flush | <symptom> A sensation of heat and flushing that occurs suddenly. May be associated with menopause or some medications. (09 Oct 1997) |
| flush | <clinical sign> Transient, episodic redness of the face and neck caused by certain diseases, ingestion of certain drugs or other substances, heat, emotional factors or physical exertion. (18 Nov 1997) |
| flush end | <molecular biology> The ends of a blunt-end DNA molecule, where both strands in the double-stranded DNA molecule are even with each other rather than one strand being longer than the other. (09 Oct 1997) |
| flush technique | <procedure> A technique for determining the systolic blood pressure in infants; the elevated limb is milked of blood from the hand or foot proximally; the blood pressure cuff is then inflated above the likely systolic pressure and the limb lowered; the cuff pressure is then gradually released until the blanched limb flushes. (05 Mar 2000) |
| augmented histamine test | A test for maximal production of gastric acidity or anacidity; after preliminary administration of an antihistamine, histamine acid phosphate is injected subcutaneously in a dose of 0.04 mg/kg of body weight, followed by analysis of gastric contents. Synonym: augmented histamine test. (05 Mar 2000) |
| receptors, histamine | Cell-surface proteins that bind histamine and trigger intracellular changes influencing the behaviour of cells. Histamine receptors are widespread in the central nervous system and in peripheral tissues. Three types have been recognised and designated h1, h2, and h3. They differ in pharmacology, distribution, and mode of action. (12 Dec 1998) |
| receptors, histamine h1 | A class of histamine receptors discriminated by their pharmacology and mode of action. most histamine h1 receptors operate through the inositol phosphate/diacylglycerol second messenger system. Among the many responses mediated by these receptors are smooth muscle contraction, increased vascular permeability, hormone release, and cerebral glyconeogenesis. (12 Dec 1998) |
| receptors, histamine h2 | A class of histamine receptors discriminated by their pharmacology and mode of action. Histamine h2 receptors act via g-proteins to stimulate adenylate cylase. Among the many responses mediated by these receptors are gastric acid secretion, smooth muscle relaxation, inotropic and chronotropic effects on heart muscle, and inhibition of lymphocyte function. (12 Dec 1998) |
| receptors, histamine h3 | A class of histamine receptors discriminated by their pharmacology and mode of action. Histamine h3 receptors were first recognised as inhibitory autoreceptors on histamine-containing nerve terminals and have since been shown to regulate the release of several neurotransmitters in the central and peripheral nervous systems. (12 Dec 1998) |
| histamine | <biochemistry> Formed by decarboxylation of histidine. Potent pharmacological agent acting through receptors in smooth muscle and in secretory systems. Stored in mast cells and released by antigen. (See hypersensitivity). Responsible for the early symptoms of anaphylaxis. Also present in some venoms. (18 Nov 1997) |
| histamine agents | Drugs used for their actions on histaminergic systems. Included are drugs that act at histamine receptors, affect the life cycle of histamine, or affect the state of histaminergic cells. (12 Dec 1998) |
| histamine agonist | Drugs that bind to and activate histamine receptors. Although they have been suggested for a variety of clinical applications histamine agonists have so far been more widely used in research than therapeutically. (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|